Blog Posts

News Alert

RFK Jr. Tells Senate Panel 340B Program ‘Controversial’ But Important to Rural Hospitals; HHS Releases MFN Targets for Drugmakers

HHS Secretary Robert F. Kennedy Jr. told a Senate subcommittee Tuesday that the 340B program plays an important role for rural hospitals despite being “very controversial."
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. told a U.S. Senate subcommittee Tuesday that the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers Applaud Federal Judge’s 340B Rebate Ruling as Drugmakers Mull Next Steps

340B stakeholders are reacting to U.S District Judge Dabney Friedrich's May 15 ruling on a series of controversial drugmaker 340B rebate lawsuits.
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judges Allows 340B Hospital Advocacy Group to Intervene in J&J Rebate Lawsuit

A federal district judge in Washington, D.C. will allow a hospital advocacy group to intervene in another drugmaker 340B rebate lawsuit.
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

Safeguarding Your 340B Program

SPONSORED CONTENT

Introduction: Navigating Political Headwinds

As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement

Read More »

California Assembly Passes 340B Contract Pharmacy Protections for Grantees, Sends Bills to Senate

California state assembly members voted by a 44-6 margin to pass a 340B contract pharmacy access bill on May 19.
The California Assembly yesterday approved a bill to prohibit manufacturers from placing 340B contract pharmacy restrictions on grantee covered entities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

ADAP Advocacy, a drug industry funded group, recently released a minute-long ad that argues 340B unduly benefits providers and could be rife with “fraud, waste and abuse.”
A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Viatris, Amgen, GSK Announce 340B Refunds; Amgen Issues NDC Change

Viatris and two other drugmakers recently issued notices to 340B covered entities.
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Oklahoma Governor Vetoes 340B Contract Pharmacy Access Bill Despite Near-Unanimous Legislative Support

Oklahoma Gov. Kevin Stitt (R) on May 17 vetoed a 340B contract pharmacy access bill that had passed the state legislature by wide margins.
Oklahoma Gov. Kevin Stitt (R) on Saturday vetoed a 340B contract pharmacy access despite it passing the Republican-controlled state legislature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Vermont Senate Passes Combined 340B Contract Pharmacy Access and Hospital Reporting Bill

The Vermont Senate approved a 340B contract pharmacy access bill with hospital reporting requirements on May 15.
Vermont state senators voted by voice Thursday to pass a 340B contract pharmacy access bill with recently added reporting requirements [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Federal Judge Upholds HHS’ Right to Pre-Approve 340B Rebates, Tosses Four of Five Drugmaker Lawsuits

Judge Dabney Friedrich of the U.S. District Court for the District of Columbia largely sided with HHS and against the drug industry in multiple 340B rebate lawsuits.
A federal district judge has upheld the federal government’s authority to require agency approval of drugmaker 340B rebate models, dealing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live